Enhancing Medicare and FDA Regulations for Better Patient Outcomes
Explore recent bipartisan legislation enhancing Medicare and FDA regulations to improve patient outcomes and access to medical devices for beneficiaries.
Explore recent bipartisan legislation enhancing Medicare and FDA regulations to improve patient outcomes and access to medical devices for beneficiaries.
Learn about new measures targeting Medicare and Medicaid fraud, including enrollment freezes and increased investigations to protect against fraudulent activities.
Explore the Trump administration's new initiatives to combat healthcare fraud in Medicare and Medicaid, aiming to protect taxpayer interests and improve program integrity.
Explore CMS's proposed changes to the Skilled Nursing Facility Payment System and their impact on payment structures and patient care improvements.
Discover how telemedicine's growth during COVID-19 affected healthcare costs and medical visits according to recent UCLA research, highlighting key policy changes.
Discover key actions by the Trump administration to combat Medicare and Medicaid fraud, including a six-month moratorium on new provider enrollments.
Learn about the new Medicare enrollment freeze aimed at preventing fraud in healthcare services, vital for maintaining resources for genuine patients.
Federal suspension of new home health and hospice Medicare providers to combat fraud. Ensures patient care and compliance while addressing billing practices.
The Trump administration pauses Medicare enrollments for home health and hospice providers to address extensive fraud concerns and enhance regulatory compliance measures.
Explore insights from a study on telemedicine's impact on healthcare visits and spending across different insurance types, revealing critical accessibility challenges.